Kerry Wentworth
CIK 1369453 · CHIEF REGULATORY OFFICER · last filed 2026-04-21
Kerry Wentworth is a CHIEF REGULATORY OFFICER who has filed 71 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for NUVB, was dated Apr 21, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $631.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$631.0K
4
71
-$1.20M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NUVB | CHIEF REGULATORY OFFICER | 89,750 | $4.92 | $441.6K | -$1.09M | 3 | 2026-04-21 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | CHIEF REGULATORY OFFICER | 50,000 | $0.01 | $255 | $89.7K | 6 | 2025-06-18 |
| FLXN | Chief Regulatory Officer | 0 | $25.05 | $0 | -$109.1K | 17 | 2021-11-19 |
| AGEN | VP, Clinical, Reg & Qual | 57,410 | $3.30 | $189.5K | -$90.9K | 45 | 2014-02-28 |
Recent Filings
71 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-21 | NUVB | Mixed | — | -$76.6K | EDGAR |
| 2026-04-08 | NUVB | Mixed | — | -$522.6K | EDGAR |
| 2026-03-03 | NUVB | Grant (A) | — | $0 | EDGAR |
| 2025-06-18 | Nuvation Bio Inc. (NUVB.WS) Delisted | Buy (P) | +50,000 | $89.7K | EDGAR |
| 2025-03-04 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-04 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-02 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-31 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-25 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-19 | FLXN | Disp (D) | −146,843 | -$1.25M | EDGAR |